Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema in Eyes with Branch Retinal Vein Occlusion with vs Without Glaucoma - Does Glaucoma Affect Visual Outcome in Eyes with BRVO-ME After antiVEGF Injections?

被引：2

作者：

Asami, Shin ^{[1
]}

Sugimoto, Masahiko ^{[1
]}

Tsukitome, Hideyuki ^{[1
]}

Kato, Kumiko ^{[1
]}

Matsubara, Hisashi ^{[1
]}

Kondo, Mineo ^{[1
]}

机构：

[1] Mie Univ, Dept Ophthalmol, Grad Sch Med, 2-174 Edobashi, Tsu, Mie 5148507, Japan

来源：

CLINICAL OPHTHALMOLOGY | 2022年 / 16卷

关键词：

anti -vascular endothelial growth factor treatment; branch retinal vein occlusion; glaucoma; macular edema; RISK-FACTORS; BLOOD-FLOW; PROGRESSION; DIAGNOSIS;

D O I：

10.2147/OPTH.S356727

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Purpose: To compare the therapeutic effects of anti-vascular endothelial growth factor (anti-VEGF) agents in eyes with macular edema associated with branch retinal vein occlusion (BRVO-ME) with glaucoma to those without glaucoma.Patients and Methods: This retrospective study was conducted using the medical records of Mie University Hospital from 2013 to 2017. Patients were recruited if they had received anti-VEGF agents for BRVO-ME treatment and included 30 patients (30 eyes) without glaucoma (G[-] group) and 27 patients (27 eyes) with glaucoma (G[+] group). The central retinal thickness (CRT) and bestcorrected visual acuity (BCVA) at 3 months after a single injection of anti-VEGF agents were compared between the two groups.Results: Before treatment, the mean +/- standard deviation of the CRT was 514.2 +/- 117.3 gm for the G[-] group, which was not significantly different from that for the G[+] group (533.4 +/- 171.4 gm). The CRT in the G[-] and G[+] groups significantly reduced to 321.1 +/- 114.6 gm and 347.8 +/- 134.7 gm, respectively, at 1 month after the injection and to 360.4 +/- 159.5 gm and 352.4 +/- 151.9 gm, respectively, at 3 months after the injection (P<0.01 for each group). The difference in the degree of CRT reduction between the two groups was not significant. Before treatment, the BCVA was 0.42 +/- 0.32 logMAR units in the G[-] group and 0.57 +/- 0.33 logMAR units in the G[+] group, showing no significant difference. The BCVA in the G[-] and G[+] groups improved significantly to 0.27 +/- 0.26 logMAR units and 0.34 +/- 0.42 logMAR units, respectively, at 1 month, and to 0.18 +/- 0.20 logMAR units and 0.39 +/- 0.34 logMAR units, respectively, at 3 months (P<0.01). The BCVA in the G[-] group was significantly better than that in the G[+] group at 3 months (P=0.02).Conclusion: The therapeutic response of anti-VEGF agents for BRVO-ME is affected by the presence of glaucoma.

引用

页码：2275 / 2283

页数：9

共 31 条

[21] Efficacy of subthreshold micropulse laser photocoagulation therapy versus anti-vascular endothelial growth factor therapy for refractory macular edema secondary to non-ischemic branch retinal vein occlusion [J].

Feng, Xiaoxiao ;

Li, Yunqin ;

Wu, Min ;

Dan, Aihua ;

Yang, Wenzhi ;

Peng, Yali ;

Xiao, Libo .

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2023, 51 (08)

[22] Pars Plana Vitrectomy Combined with Internal Limiting Membrane Peeling to Treat Persistent Macular Edema after Anti-Vascular Endothelial Growth Factor Treatment in Cases of Ischemic Central Retinal Vein Occlusion [J].

Shirakata, Yukari ;

Fujita, Tomoyoshi ;

Nakano, Yuki ;

Shiraga, Fumio ;

Tsujikawa, Akitaka .

CASE REPORTS IN OPHTHALMOLOGY, 2016, 7 (01) :1-8

[23] Long-Term Visual Outcomes in Neovascular Age- Related Macular Degeneration Eyes With Baseline Macular Atrophy on Anti-Vascular Endothelial Growth Factor Treatment [J].

Foster, Michael J. ;

Shaia, Jacqueline ;

Maatouk, Christopher M. ;

Urbano, Catherine A. ;

Bui, Mark T. ;

Hom, Grant L. ;

Kuo, Blanche L. ;

Singh, Rishi P. ;

Talcott, Katherine E. .

OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2023, 54 (04) :223-230

[24] Intravitreal Injection of Anti-Vascular Endothelial Growth Factors Combined with Corticosteroids for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion: A Systematic Review and Meta-Analysis [J].

Namvar, Ehsan ;

Yasemi, Masoud ;

Nowroozzadeh, M. Hossein ;

Ahmadieh, Hamid .

SEMINARS IN OPHTHALMOLOGY, 2024, 39 (01) :109-119

[25] Intravitreal Injection of Anti-Vascular Endothelial Growth Factors Combined with Corticosteroids for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion: A Systematic Review and Meta-Analysis [J].

Namvar, Ehsan ;

Yasemi, Masoud ;

Nowroozzadeh, M. Hossein ;

Ahmadieh, Hamid .

SEMINARS IN OPHTHALMOLOGY, 2023,

[26] The correlation between cytokine levels in the aqueous humor and the prognostic value of anti-vascular endothelial growth factor therapy for treating macular edema resulting from retinal vein occlusion [J].

Yong, Hongfang ;

Qi, Hui ;

Yan, Hongtao ;

Wu, Qianqian ;

Zuo, Ling .

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2021, 259 (11) :3243-3250

[27] The correlation between cytokine levels in the aqueous humor and the prognostic value of anti-vascular endothelial growth factor therapy for treating macular edema resulting from retinal vein occlusion [J].

Hongfang Yong ;

Hui Qi ;

Hongtao Yan ;

Qianqian Wu ;

Ling Zuo .

Graefe's Archive for Clinical and Experimental Ophthalmology, 2021, 259 :3243-3250

[28] Retinal pigment epithelial characteristics in eyes with neovascular age-related macular degeneration Long-term retinal changes under anti-vascular endothelial growth factor treatment [J].

Ebner, Christian ;

Wernigg, Clara ;

Schuetze, Christopher ;

Weingessel, Birgit ;

Vecsei-Marlovits, Pia-Veronika .

WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (3-4) :123-130

[29] Two-Week Central Macular Thickness Reduction Rate >37% Predicts the Long-Term Efficacy of Anti-vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Retinal Vein Occlusion [J].

Zhou, Jialin ;

Ma, Huafeng ;

Zhou, Xiyuan ;

Wang, Qiuyu ;

Li, Weihou ;

Luo, Shuai ;

Cai, Chang ;

Li, Zefeng ;

Liu, Danning .

FRONTIERS IN MEDICINE, 2022, 9

[30] Comparison between Ozurdex and intravitreal anti-vascular endothelial growth factor treatment for retinal vein occlusion-related macular edema: A systematic review and meta-analysis of randomized controlled trials [J].

Hu, Qiuming ;

Li, Haoyu ;

Xu, Wenhua ;

Du, Yi ;

Ma, Chao ;

He, Jianfeng .

INDIAN JOURNAL OF OPHTHALMOLOGY, 2019, 67 (11) :1800-1809

← 1 2 3 4 →